APA (7th ed.) Citation

MS, L., JJ, A., D, T., R, V., HYG, L., S, Y., . . . A, P. (2023). Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma. Small (Weinheim an der Bergstrasse, Germany), 19(52), e2302280. https://doi.org/10.1002/smll.202302280

Chicago Style (17th ed.) Citation

MS, Lam, et al. "Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma." Small (Weinheim an Der Bergstrasse, Germany) 19, no. 52 (2023): e2302280. https://doi.org/10.1002/smll.202302280.

MLA (9th ed.) Citation

MS, Lam, et al. "Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma." Small (Weinheim an Der Bergstrasse, Germany), vol. 19, no. 52, 2023, p. e2302280, https://doi.org/10.1002/smll.202302280.